ASRA Coags vs its rivals

Side-by-side comparison against ASRA Coags's closest competitors — identity, store metrics, ratings & sentiment, and strategic intel.

ASRA Coags
This App
Pedi STAT
New Kid
Core Identity
DeveloperAmerican Society of Regional Anesthesia and Pain MedicineVargo Anesthesia IncUnbound Medicine, Inc.DoximityUpToDate, Inc.WebMDMD Aware, LLCJames M Kempema MD PA
CategoryMedicalMedicalMedicalMedicalMedicalMedicalMedicalMedical
PlatformiOS, AndroidAndroid, iOSiOS, AndroidAndroid, iOSAndroid, iOSiOS, AndroidiOS, AndroidAndroid, iOS
Store Metrics
Rating1.3 / 54.7 / 54.7 / 54.8 / 53.7 / 54.8 / 54.9 / 54.5 / 5
Ratings Count362158103191,4515285,08651,24764
PriceFree$99.99FreeFreeFreeFreeFree$5.99
Release DateApr 14, 2014Jan 9, 2014Dec 24, 2009Sep 29, 2010Apr 15, 2011Mar 20, 2010Mar 7, 2016Aug 29, 2009
Last UpdatedDec 3, 2025Mar 19, 2026Dec 18, 2025Apr 17, 2026Feb 24, 2026Dec 19, 2025Feb 2, 2026Nov 6, 2025
Sentiment & Reviews
Sentimentterrible---terrible---
Score15/100---15/100---
Praises
  • Clinical utility of the perioperative anticoagulant scheduling tool remains highly valued by medical professionals
---
  • High quality clinical content remains the primary reason for long-term professional reliance
---
Complaints
  • Forced subscription model revokes lifetime access previously purchased by long-term medical professional users
  • Lack of grandfathering for legacy users creates significant friction and loss of trust in the brand
---
  • Persistent application freezing during search and article loading renders the tool unusable
---
Requests
  • Restoration of access for users who previously paid for lifetime ownership of the application
---
  • Concise article summaries with optional links for atomic level detail
---
Strategic Intel
Strengths
  • Society-sanctioned clinical standards function as a primary distribution moat for professional practitioners.
  • Procedure-based search reduces clinical decision-making time, driving daily utility.
  • Niche specialization in anesthesia workflows
  • Offline-first architecture for OR environments
  • One-time purchase model vs. subscriptions
--
  • Clinician-authored content functions as a high-switching-cost brand moat
  • Expert AI integration provides a premium-tier conversion lever
---
Weaknesses
  • Subscription transition revoked lifetime access for legacy users, triggering a 1.27-star rating floor.
  • Technical instability and crashes reported following the latest update.
  • High $99.99 upfront cost barrier
  • Static content updates vs. weekly evidence feeds
  • Lack of automated drug dose calculations
--
  • Persistent search-result freezing drives high churn risk
  • Offline mode failure prevents access in remote clinical settings
---
Pricingsubscriptionpaidsubscriptionfreesubscriptionfreefreepaid
MomentumSteadyMaintenanceSteadyIntenseActiveSteadyActiveSteady
Update Cadence5 versions5 versions, ~18d avg5 versions5 versions5 versions5 versions5 versions5 versions

Compare ASRA Coags head-to-head

Disclosure: Independent intel to help mobile builders succeed.

AI-powered analysis with editorial review, built from publicly available sources. Marlvel.ai is not affiliated with, endorsed by, or sponsored by ASRA Coags, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Data licensed under CC-BY-NC 4.0